Effect of renal function on pemetrexed-induced haematotoxicity

Yosuke Ando, Takahiro Hayashi, Moeko Ujita, Sumie Murai, Hideki Ohta, Kaori Ito, Teppei Yamaguchi, Minori Funatsu, Yoshiaki Ikeda, Kazuyoshi Imaizumi, Kenji Kawada, Kimio Yasuda, Shigeki Yamada

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Purpose: Pemetrexed (PEM) is an anticancer agent used for the treatment of non-small cell lung cancer, malignant pleural mesothelioma and thymoma. Reportedly, PEM has higher efficacy and safety when used in combination with platinum-based agents. However, there are only few reports on the safety of PEM in patients with an eGFR of ≤45 mL/min. We examined the effect of renal function on the safety of regimens containing PEM. Methods: We retrospectively reviewed 221 patients with lung cancer, malignant pleural mesothelioma or thymoma who received treatment with a PEM-containing regimen between 2009 and 2014. Subgroup analyses were performed on the basis of pre-treatment renal function: group A [creatinine clearance (CLcr), <45 mL/min]; group B (CLcr, 45–80 mL/min); and group C (CLcr, ≥80 mL/min). For the purpose of this analysis, the lowest documented blood cell counts and haemoglobin levels, the highest levels of serum creatinine, aspartate aminotransferase, alanine aminotransferase and CLcr from the time of initial administration up to prior to the start of second administration were considered. Results: Groups A, B and C had 8, 123 and 90 patients, respectively. The incidence of grade 2 thrombocytopaenia was significantly higher in group A as compared to that in groups B (P < 0.01) and C (P < 0.05). On multivariate analysis, only a CLcr of <45 mL/min was an independent risk factor for thrombocytopaenia of ≥grade 2. Conclusion: When administering a PEM-containing regimen, thrombocytopaenia of ≥grade 2 is more likely to develop in patients with a CLcr of <45 mL/min.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalCancer Chemotherapy and Pharmacology
Issue number1
Publication statusPublished - 01-07-2016

All Science Journal Classification (ASJC) codes

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)


Dive into the research topics of 'Effect of renal function on pemetrexed-induced haematotoxicity'. Together they form a unique fingerprint.

Cite this